Clinical decision support

The EMR-linked tool has been implemented across 16 departments.

The lack of a strong set of AI-specific regulation in the U.S. allows innovation to happen quickly, but that also requires companies to be transparent and for the industry to take responsibility for its own actions, says Mika Newton, CEO of xCures.  

According to Julia Zarb, Blue x Blue CEO and founder, embracing complexity, developing strong analytical skills and understanding common sensibilities and values can help newcomers succeed in the health IT field.

Also, South Korean medical AI companies JLK and Coreline Soft announced recent regulatory approvals in Japan and the United States.

The company, spun out of MIT and backed by Define Ventures, GV and Flare Capital Partners, was founded by veteran AI and clinical leaders from MIT, Harvard, Microsoft and Google.

Developers at the Chinese University of Hong Kong claim it "communicates like a real doctor." 

Also, a new AI model potentially enhances endometrial cancer diagnosis by achieving near full accuracy in a latest study in Australia.

Also, two Korean digital dentistry solutions providers are integrating AI into their dental diagnostic software.

The company will use the funds to accelerate commercial expansion of its ANNE One medical wearable in the United States and Europe.

While the First Databank's tool already delivers EHR-based clinical decision support, it now offers more personalized guidance when lab results reveal a medication-related problem, says Virginia Halsey, the company's SVP of strategy.